Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients.
about
Stathmin is dispensable for tumor onset in miceStathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma.Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo.Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis.Stathmin: a protein with many tasks. New biomarker and potential target in cancer.Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells.High expression of stathmin 1 is a strong prognostic marker in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.Expression of Sialyl Lewis a, Sialyl Lewis x, Lewis y, Gal-3, Gal-7, STMN1 and p16 in cervical dysplasia.Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling.Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse.Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma.Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer.STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?Developmental hypothyroxinaemia and hypothyroidism limit dendritic growth of cerebellar Purkinje cells in rat offspring: involvement of microtubule-associated protein 2 (MAP2) and stathmin.High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction.Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer.
P2860
Q21134036-65AF9C86-58FD-4906-863C-F8D532F46E39Q34217592-47D57840-3760-4342-927E-4D303FA28A90Q36080919-227B00EE-B077-4289-B214-38EFFA374FC6Q36642789-F72443E1-80EB-4DDC-9F89-C36871352C69Q37359873-0269C59F-BDA3-4C1F-8424-76EAD6B1ADDDQ37694739-A96201FA-A74F-42AE-85B6-3745DFA92D49Q37942978-02FA77C5-BF26-496D-903C-C36141C121DBQ38633682-DF0C1BBD-D2F6-4B6C-B88C-9247A7CD5996Q38817928-6F36D822-7B69-4D05-AF64-F538485126AAQ38819632-8463CFF4-C401-42C0-9FDE-0E678758D006Q38952182-C6B631ED-FF4F-4CEB-9F0C-ECD9065249B3Q39005616-AE57C544-94DB-4D5B-BC08-0081CF3DC5D2Q39064242-E692727C-89EE-48E6-829D-317DD9DDC71BQ46284216-60EB8E3C-EC99-4CE8-B951-994FFCBF55CEQ46373414-6A134135-8AF8-4AEA-B914-7D4D59B00784Q48032390-703844C1-055B-474B-A2B9-C451EFCF1C58Q51685400-5F51DEF1-21BA-4B06-AEFA-557477F3FC46Q53536522-6628DFD5-CEB0-447F-8F0E-97568343F08E
P2860
Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Expression of stathmin/op18 as ...... r cervical carcinoma patients.
@en
Expression of stathmin/op18 as ...... r cervical carcinoma patients.
@nl
type
label
Expression of stathmin/op18 as ...... r cervical carcinoma patients.
@en
Expression of stathmin/op18 as ...... r cervical carcinoma patients.
@nl
prefLabel
Expression of stathmin/op18 as ...... r cervical carcinoma patients.
@en
Expression of stathmin/op18 as ...... r cervical carcinoma patients.
@nl
P2093
P2860
P1476
Expression of stathmin/op18 as ...... r cervical carcinoma patients.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00432-008-0520-1
P577
2008-11-26T00:00:00Z